Obesity and recurrence-free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C-Reference-Cited by-同舟云学术

Obesity and recurrence-free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C

Published:2018-06-22 Issue:4 Volume:2 Page:319-326
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Ann Gastroenterol Surg

Author:

Shinkawa Hiroji¹^ORCID,Tanaka Shogo¹,Takemura Shigekazu¹,Ito Tokuji¹,Aota Takanori¹,Koda Masaki¹,Miyazaki Toru¹,Yamamoto Takatsugu²,Kubo Shoji¹^ORCID

Affiliation:

1. Department of Hepato-Biliary-Pancreatic Surgery; Osaka City University Graduate School of Medicine; Osaka Japan

2. Department of Surgery; Asakayama General Hospital; Sakai Japan

Publisher

Wiley

Subject

Gastroenterology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ags3.12183/fullpdf

Reference29 articles.

1. National trends in surgical procedures for hepatocellular carcinoma: 1998-2008;Nathan;Cancer,2012

2. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy;Yoshida;Ann Intern Med,1999

3. Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C;Tanaka;World J Gastroenterol,2007

4. Risk of hepatocellular carcinoma in patients with hepatitis C virus who achieved sustained virological response;Kudo;Liver Cancer,2016

5. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy;Tokita;J Gastroenterol Hepatol,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography;Journal of Clinical Medicine;2024-03-09

2. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma;Hepatology International;2022-03-26

3. Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct‐acting anti‐virals;Alimentary Pharmacology & Therapeutics;2021-10-07

4. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA);Cancers;2021-09-24

5. Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status;Scientific Reports;2021-03-12